| Peer-Reviewed

Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in Known Type 2 Diabetic Mellitus

Received: 20 August 2022    Accepted: 3 September 2022    Published: 16 September 2022
Views:       Downloads:
Abstract

Remission of diabetes mellitus could be an ideal solution to prevent impact of the pandemic of non-communicable disease in India. This study sought to understand the extent to which Ayurveda can impact remission of diabetes mellitus and achieve good glycaemic control in patients with diabetes mellitus. A retrospective, observational, single-centre study was conducted between 2018 and 2022 in Maharashtra, India. Patients aged 18 years and older with a diagnosis of diabetes mellitus, regardless of underlying comorbidities participated in the CDC program and were therefore included in this study. Follow-up was conducted at 30, 60, and 90 days. Day 1 and day 90 data were compared. A total of 63 patients were assessed. Of the 63 patients, 77.0% demonstrated post prandial normoglycemia, 50.8% demonstrated remission of diabetes mellitus, and 22.2% remained positive for diabetes mellitus. Variables such as weight (day1: 70.70 ± 9.82 kg and day 90: 65.15 ± 9.93 kg; p < 0.001), body mass index (day 1: 27.00 ± 3.88 and day 90: 24.91 ± 3.75; p < 0.001), abdomen girth (day 1: 98.13 ± 10.08 cm and day 90: 89.24 ± 8.40 cm; p < 0.001), and glycated haemoglobin A1c (HbA1c) levels (day 1: 7.87 ± 1.90% and day 90: 5.79 ± 0.51; p < 0.001) decreased significantly. The improvement in HbA1c levels and other risk factors through implementation to improve glucose metabolism can help restore euglycemic status in 12 weeks of time with adherence to the CDC program. Remission of diabetes mellitus may be dependent on patients’ compliance to a low carbohydrate diet provided during the treatment period.

Published in International Journal of Diabetes and Endocrinology (Volume 7, Issue 3)
DOI 10.11648/j.ijde.20220703.18
Page(s) 91-95
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Ayurveda, Cardiovascular Diseases, Body Mass Index, Diabetes Mellitus, Dietary Management, Obesity, Remission of Type 2 Diabetes Mellitus, Restoration of Euglycemia

References
[1] Ranasinghe, P., Jayawardena, R., Gamage, N., Sivanandam, N., Misra, A. (2021). Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Ann Epidemiol, 58 (25), 128–48. doi: 10.1016/j.annepidem.2021.02.016.
[2] Cade WT. (2008). Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther, 88 (11): 1322–35. doi: 10.2522/ptj.20080008.
[3] Chaudhury, A., Duvoor, C., Reddy, Dendi VS., Kraleti, S., Chada, A., and Ravilla, R, et al. (2017). Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne), 8 (6). doi: 10.3389/fendo.2017.00006.
[4] Gordon, A., Buch, Z., Baute, V., Coeytaux, R. (2019). Use of Ayurveda in the treatment of type 2 diabetes mellitus. Glob Adv Heal Med, 8, 1-6. doi: 10.1177/2164956119861094.
[5] Kumari, S., S. D, L., B, S., Khanal, S. (2022). Efficacy of integrated Ayurveda treatment protocol in type 2 diabetes mellitus – A case report. J Ayurveda Integr Med, 13 (1), 100512. doi: 10.1016/j.jaim.2021.08.005.
[6] Nair D. (2017). Understanding the role of Ayurveda Panchakarma therapy W. S. R. to Vasthi (Enema) in the management of type II diabetes mellitus- A case review. Int J Complement Altern Med, 8 (6), 6-7. doi: 10.21474/IJAR01/5175.
[7] Vaibhavi, B., Satyam, T., Sanjibkumar, P., Raghuram, N., Ramarao NH. (2013). Effect of holistic module of yoga and Ayurvedic Panchakarma in type 2 diabetes mellitus—A pilot study. Open J Endocr Metab Dis, 3 (01), 90–8. doi: 10.4236/ojemd.2013.31014.
[8] Semwal, DK., Semwal, RB., Chauhan, A., Mishra, SP. (2016). Treatment of Type 2 Diabetes with Ayurveda: A Case Report. Pharmacologia, 7 (4), 239-42. doi: 10.5567/pharmacologia.2016.239.242.
[9] Kumari, J., Mehta, CS., Shukla, VD., Dave, AR., Shingala, TM. (2010). A comparative clinical study of Nyagrodhadi Ghanavati and Virechana Karma in the management of Madhumeha. Ayu, 31 (3), 300-4. doi: 10.4103/0974-8520.77152.
[10] Tanna, I., Chandola, HM., Joshi. JR. Clinical efficacy of Mehamudgara vati in type 2 diabetes mellitus. (2011). Ayu, 2 (1), 30-9. doi: 10.4103/0974-8520.85722.
[11] Chattopadhyay, K., Wang, H., Kaur, J., Nalbant, G., Almaqhawi, A., and Kundakci, B., et al. (2022). Effectiveness and safety of ayurvedic medicines in type 2 diabetes mellitus management: A systematic review and meta-analysis. Front Pharmacol, 8 (13), 821810. doi: 10.3389/fphar.2022.821810.
[12] American Diabetes Association. (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care, 36 Suppl 1 (Suppl 1), S67-74. doi: 10.2337/dc13-S067.
[13] Sane, R., A, SI., S, NM, Tejaswini, S., S, MR, (2018). To study efficacy of Comprehensive Diabetes Care (CDC) management program in type II diabetic obese patients: An observational study. Int J Ayurveda Pharma Res, 6 (6), 6–12.
[14] Sane, R., Ghadigaonkar, P., Chaure, R., Jain, S., Wahane, S., Nadapude, A., and Badre, A. et al. (2018). Efficacy of Comprehensive Diabetes Care (CDC) management program in elderly male patients of type II diabetes mellitus: A retrospective study. Int J Diabetes Endocrinol; 3 (2), 29. doi: 10.11648/j.ijde.20180302.12.
[15] Sane, R., Naik, M., Khair, K., Mahajan, H., Pawar, D., and Revandkar, V., et al. (2018). Effect of comprehensive diabetes care on glycaemic control with reduction in dependency of oral hypoglycaemic medicines in pre-obese diabetic patients: A retrospective study. Int J Curr Res Acad Rev, 6 (11), 73–81 doi: 10.20546/ijcrar.2018.611.009.
[16] Atre S. The burden of diabetes in India. (2019). Lancet Glob Health, 7 (4), e418. doi: 10.1016/S2214-109X(18)30556-4.
[17] Misra, A., Singhal, N., Sivakumar, B., Bhagat, N., Jaiswal, A., and Khurana, L. (2011). Nutrition transition in India: Secular trends in dietary intake and their relationship to diet-related non-communicable diseases. J Diabetes. 3 (4), 278-92. doi: 10.1111/j.1753-0407.2011.00139.x.
[18] Gopalan, HS., Misra, A., Jayawardena, R. Nutrition and diabetes in South Asia. Eur J Clin Nutr. (2018). 72 (9), 1267–73. Doi: 10.1038/s41430-018-0219-6.
[19] Tripathy, JP., Thakur, JS., Jeet, G., Chawla, S., Jain, S., and Prasad, R. (2016). Urban rural differences in diet, physical activity and obesity in India: Are we witnessing the great Indian equalisation? Results from a cross-sectional STEPS survey. BMC Public Health, 16 (1), 1–10. doi: 10.1186/s12889-016-3489-8.
[20] Ranasinghe, CD., Ranasinghe, P., Jayawardena, R., Misra, A. (2013) Physical activity patterns among South-Asian adults: A systematic review. Int J Behav Nutr Phys Act. 12 (10), 116. doi: 10.1186/1479-5868-10-116.
[21] Hills, AP., Arena, R., Khunti, K., Yajnik, CS., Jayawardena, R., and Henry, CJ., et al. (2018). Epidemiology and determinants of type 2 diabetes in south Asia. Lancet Diabetes Endocrinol, 6 (12), 966-78. doi: 10.1016/S2213-8587(18)30204-3.
Cite This Article
  • APA Style

    Tejaswini Nandakumar Shingan, Swati Kamlapure, Nilesh Kulthe. (2022). Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in Known Type 2 Diabetic Mellitus. International Journal of Diabetes and Endocrinology, 7(3), 91-95. https://doi.org/10.11648/j.ijde.20220703.18

    Copy | Download

    ACS Style

    Tejaswini Nandakumar Shingan; Swati Kamlapure; Nilesh Kulthe. Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in Known Type 2 Diabetic Mellitus. Int. J. Diabetes Endocrinol. 2022, 7(3), 91-95. doi: 10.11648/j.ijde.20220703.18

    Copy | Download

    AMA Style

    Tejaswini Nandakumar Shingan, Swati Kamlapure, Nilesh Kulthe. Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in Known Type 2 Diabetic Mellitus. Int J Diabetes Endocrinol. 2022;7(3):91-95. doi: 10.11648/j.ijde.20220703.18

    Copy | Download

  • @article{10.11648/j.ijde.20220703.18,
      author = {Tejaswini Nandakumar Shingan and Swati Kamlapure and Nilesh Kulthe},
      title = {Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in Known Type 2 Diabetic Mellitus},
      journal = {International Journal of Diabetes and Endocrinology},
      volume = {7},
      number = {3},
      pages = {91-95},
      doi = {10.11648/j.ijde.20220703.18},
      url = {https://doi.org/10.11648/j.ijde.20220703.18},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijde.20220703.18},
      abstract = {Remission of diabetes mellitus could be an ideal solution to prevent impact of the pandemic of non-communicable disease in India. This study sought to understand the extent to which Ayurveda can impact remission of diabetes mellitus and achieve good glycaemic control in patients with diabetes mellitus. A retrospective, observational, single-centre study was conducted between 2018 and 2022 in Maharashtra, India. Patients aged 18 years and older with a diagnosis of diabetes mellitus, regardless of underlying comorbidities participated in the CDC program and were therefore included in this study. Follow-up was conducted at 30, 60, and 90 days. Day 1 and day 90 data were compared. A total of 63 patients were assessed. Of the 63 patients, 77.0% demonstrated post prandial normoglycemia, 50.8% demonstrated remission of diabetes mellitus, and 22.2% remained positive for diabetes mellitus. Variables such as weight (day1: 70.70 ± 9.82 kg and day 90: 65.15 ± 9.93 kg; p < 0.001), body mass index (day 1: 27.00 ± 3.88 and day 90: 24.91 ± 3.75; p < 0.001), abdomen girth (day 1: 98.13 ± 10.08 cm and day 90: 89.24 ± 8.40 cm; p < 0.001), and glycated haemoglobin A1c (HbA1c) levels (day 1: 7.87 ± 1.90% and day 90: 5.79 ± 0.51; p < 0.001) decreased significantly. The improvement in HbA1c levels and other risk factors through implementation to improve glucose metabolism can help restore euglycemic status in 12 weeks of time with adherence to the CDC program. Remission of diabetes mellitus may be dependent on patients’ compliance to a low carbohydrate diet provided during the treatment period.},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Role of Ayurveda Based Comprehensive Diabetic Care Program in Restoration of Euglycemia in Known Type 2 Diabetic Mellitus
    AU  - Tejaswini Nandakumar Shingan
    AU  - Swati Kamlapure
    AU  - Nilesh Kulthe
    Y1  - 2022/09/16
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ijde.20220703.18
    DO  - 10.11648/j.ijde.20220703.18
    T2  - International Journal of Diabetes and Endocrinology
    JF  - International Journal of Diabetes and Endocrinology
    JO  - International Journal of Diabetes and Endocrinology
    SP  - 91
    EP  - 95
    PB  - Science Publishing Group
    SN  - 2640-1371
    UR  - https://doi.org/10.11648/j.ijde.20220703.18
    AB  - Remission of diabetes mellitus could be an ideal solution to prevent impact of the pandemic of non-communicable disease in India. This study sought to understand the extent to which Ayurveda can impact remission of diabetes mellitus and achieve good glycaemic control in patients with diabetes mellitus. A retrospective, observational, single-centre study was conducted between 2018 and 2022 in Maharashtra, India. Patients aged 18 years and older with a diagnosis of diabetes mellitus, regardless of underlying comorbidities participated in the CDC program and were therefore included in this study. Follow-up was conducted at 30, 60, and 90 days. Day 1 and day 90 data were compared. A total of 63 patients were assessed. Of the 63 patients, 77.0% demonstrated post prandial normoglycemia, 50.8% demonstrated remission of diabetes mellitus, and 22.2% remained positive for diabetes mellitus. Variables such as weight (day1: 70.70 ± 9.82 kg and day 90: 65.15 ± 9.93 kg; p < 0.001), body mass index (day 1: 27.00 ± 3.88 and day 90: 24.91 ± 3.75; p < 0.001), abdomen girth (day 1: 98.13 ± 10.08 cm and day 90: 89.24 ± 8.40 cm; p < 0.001), and glycated haemoglobin A1c (HbA1c) levels (day 1: 7.87 ± 1.90% and day 90: 5.79 ± 0.51; p < 0.001) decreased significantly. The improvement in HbA1c levels and other risk factors through implementation to improve glucose metabolism can help restore euglycemic status in 12 weeks of time with adherence to the CDC program. Remission of diabetes mellitus may be dependent on patients’ compliance to a low carbohydrate diet provided during the treatment period.
    VL  - 7
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Madhavbaug Cardiac Clinic, Mumbai, India

  • Madhavbaug Cardiac Clinic, Mumbai, India

  • Madhavbaug Cardiac Clinic and Hospital, Thane, India

  • Sections